Laurie Alsup
Director/Board Member at BLACKBERRY LIMITED
Net worth: 482 532 $ as of 31/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Houston | M | 64 |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 7 years |
| Timothy Shannon | M | 65 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 11 years |
| Dean Mitchell | M | 68 | 14 years | |
| Randy Teel | M | 45 | 6 years | |
| Jakob Loven | M | 46 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 3 years |
| Richard Lynch | M | 76 | 11 years | |
| Sean Cassidy | M | 54 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 11 years |
| Steve Rai | M | - | - | |
| Wendy Dixon | M | 68 | 13 years | |
| Liam Ratcliffe | M | 60 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 9 years |
| Briggs Morrison | M | 65 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 6 years |
| Dennis Ryan | M | 69 | 1 years | |
| Phil Kurtz | M | - | - | |
| Leslie Norwalk | F | 58 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 5 years |
| Rhonda Farnum | F | 59 | 6 years | |
| John Giamatteo | M | 57 | - | |
| Bradley Margus | M | 63 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 10 years |
| Rick Winningham | M | 64 | 16 years | |
| Jeremy Grant | M | 36 | 1 years | |
| Tim Foote | M | - | - | |
| Richard Graham | M | - | - | |
| Brett Grimaud | M | 50 | 3 years | |
| Jared M. Freedberg | M | 55 | - | |
| John Grosso | M | - | - | |
| Ian Taylor | M | 61 | 8 years | |
| Lars-Helge Stromquist | M | 75 |
NDA Group AB
 NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | 27 years |
| Kimberly McCutcheon Jablonski | F | - | 21 years | |
| Aziz Sawaf | M | 42 | 10 years | |
| Aine Miller | M | 47 | - | |
| Lisa Disbrow | F | 61 | 5 years | |
| Linda Bain | F | 53 | 4 years | |
| Wayne Wouters | M | 73 | 9 years | |
| John Young | M | 60 | 2 years | |
| Michael Daniels | M | 78 | 10 years | |
| Eran Broshy | M | 65 | 10 years | |
| Deepa Pakianathan | M | 59 | 4 years | |
| Jim Kelly | M | 43 | 1 years | |
| Susannah Gray | F | 63 | 1 years | |
| Donal O'Connor | M | 73 | 9 years | |
| Edward Kennedy | M | 62 | 6 years | |
| Everett Cunningham | M | 57 | 2 years | |
| Charles Eagan | M | - | 6 years | |
| Marjorie Dickman | F | - | 4 years | |
| Kimberly Wehger | F | - | - | |
| Steve Weiss | M | 55 | 6 years | |
| Kirsten Owens | F | - | - | |
| Neelam Sandhu | F | - | - | |
| Barbara Warren | F | - | 3 years | |
| Mattias Eriksson | M | - | - | |
| Thomas Lönngren | M | 73 |
NDA Group AB
NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | 13 years |
| Göran Pettersson | M | - |
NDA Group AB
NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | - |
| Sai Yuen Ho | M | 67 | - | |
| Philip Brace | M | 53 | - | |
| Arvind Raman | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Giovanni Caforio | M | 59 | 24 years | |
| Lamberto Andreotti | M | 73 | 19 years | |
| Mark Meltz | M | 50 | 4 years | |
| Uri Lopatin | M | 52 | 3 years | |
| James Cornelius | M | 81 | 10 years | |
| Charles A. Heimbold | M | - | 20 years | |
| Stephen W. Kaldor | M | 62 | 3 years | |
| Peter R. Dolan | M | 68 | 18 years | |
| Mark Auerbach | M | 85 | 2 years | |
| Ted Love | M | 65 | 6 years | |
| Eric Murphy | M | 48 | 3 years | |
| Randall Cook | M | - | - | |
| Nima Farzan | M | 48 | 4 years | |
| Ilya Raskin | M | - |
Phytomedics, Inc.
 Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | 16 years |
| David W. Pritchard | M | 69 | 8 years | |
| Herbert Cross | M | 52 | 2 years | |
| Barbara Stymiest | F | 67 | 15 years | |
| James Healy | M | 58 | 13 years | |
| Steven Capelli | M | 66 | - | |
| Ronald Martell | M | 62 |
Kalobios Pharmaceuticals, Inc.
| - |
| Raymond M. Withy | M | 68 | 10 years | |
| Jeanne Jew | F | 61 | 7 years | |
| Bob Petrou | M | 52 | 16 years | |
| James Tananbaum | M | 60 | 4 years | |
| Donald Joseph | M | 70 | 2 years | |
| Gary Gaglione | M | 72 |
Phytomedics, Inc.
Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | 1 years |
| George M. Whitesides | M | 84 | 8 years | |
| Mark Wilson | M | - | 10 years | |
| Fouad Namouni | M | 55 | 21 years | |
| Renée Galá | F | 52 | 5 years | |
| Brett K. Haumann | M | 54 | 7 years | |
| Timothy Dattels | M | 66 | 11 years | |
| Gary Lyons | M | 73 | 4 years | |
| Joe L. del Callar | M | - | - | |
| Martin Shkreli | M | 41 | - | |
| John Chen | M | 68 | 10 years | |
| William Young | M | 79 | 10 years | |
| Susan Molineaux | M | 70 | 7 years | |
| Dennis J. Henner | M | 72 | 8 years | |
| Robert Gunderson | M | 72 | 8 years | |
| Bradford J. Shafer | M | 63 | 7 years | |
| Burt Malkiel | M | 90 | 11 years | |
| Prem Watsa | M | 74 | 11 years | |
| Peter S. Ringrose | M | 78 | 7 years | |
| Michael Rome | M | 39 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 72 | 72.73% |
| Canada | 24 | 24.24% |
| Sweden | 3 | 3.03% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Laurie Alsup
- Personal Network